These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 27881396

  • 1. Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.
    Kadiombo AT, Maeshima A, Kayakabe K, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y.
    Am J Physiol Renal Physiol; 2017 Feb 01; 312(2):F297-F304. PubMed ID: 27881396
    [Abstract] [Full Text] [Related]

  • 2. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D.
    FASEB J; 2004 Mar 01; 18(3):534-6. PubMed ID: 14734643
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L, Hu J, Chen L, Zhang Y, Wang Q, Yang X.
    Front Immunol; 2021 Mar 01; 12():584414. PubMed ID: 33717066
    [Abstract] [Full Text] [Related]

  • 4. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 01; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 5. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.
    Lema GP, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, Schlöndorff D.
    J Am Soc Nephrol; 2001 Jul 01; 12(7):1369-1382. PubMed ID: 11423566
    [Abstract] [Full Text] [Related]

  • 6. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.
    J Rheumatol; 2010 Jan 01; 37(1):60-70. PubMed ID: 19955044
    [Abstract] [Full Text] [Related]

  • 7. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/lpr mice by preventing infiltration of immune cells.
    Zhang LY, Li H, Wu YW, Cheng L, Yan YX, Yang XQ, Zhu FH, He SJ, Tang W, Zuo JP.
    Am J Physiol Renal Physiol; 2017 Apr 01; 312(4):F769-F777. PubMed ID: 28100505
    [Abstract] [Full Text] [Related]

  • 8. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
    Anders HJ, Belemezova E, Eis V, Segerer S, Vielhauer V, Perez de Lema G, Kretzler M, Cohen CD, Frink M, Horuk R, Hudkins KL, Alpers CE, Mampaso F, Schlöndorff D.
    J Am Soc Nephrol; 2004 Jun 01; 15(6):1504-13. PubMed ID: 15153561
    [Abstract] [Full Text] [Related]

  • 9. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM, Yui MA, Endres S, Burt DW, Kelley VE.
    J Immunol; 1988 Jul 01; 141(1):118-24. PubMed ID: 3259964
    [Abstract] [Full Text] [Related]

  • 10. Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice.
    Iwata Y, Boström EA, Menke J, Rabacal WA, Morel L, Wada T, Kelley VR.
    J Immunol; 2012 May 01; 188(9):4568-80. PubMed ID: 22467656
    [Abstract] [Full Text] [Related]

  • 11. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 12. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.
    Boswell JM, Yui MA, Burt DW, Kelley VE.
    J Immunol; 1988 Nov 01; 141(9):3050-4. PubMed ID: 3262676
    [Abstract] [Full Text] [Related]

  • 13. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A, Hasegawa H, Kohno M, Ito MR, Terada M, Imai T, Yoshie O, Nose M, Fujita S.
    Arthritis Rheum; 2005 May 01; 52(5):1522-33. PubMed ID: 15880599
    [Abstract] [Full Text] [Related]

  • 14. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C, Zhao ML, Scearce RM, Diaz M.
    Arthritis Rheum; 2011 Apr 01; 63(4):1086-96. PubMed ID: 21225690
    [Abstract] [Full Text] [Related]

  • 15. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
    Pérez de Lema G, Lucio-Cazaña FJ, Molina A, Luckow B, Schmid H, de Wit C, Moreno-Manzano V, Banas B, Mampaso F, Schlöndorff D.
    Kidney Int; 2004 Sep 01; 66(3):1018-28. PubMed ID: 15327395
    [Abstract] [Full Text] [Related]

  • 16. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.
    Gonzalo-Gil E, García-Herrero C, Toldos O, Usategui A, Criado G, Pérez-Yagüe S, Barber DF, Pablos JL, Galindo M.
    Front Immunol; 2018 Sep 01; 9():1948. PubMed ID: 30210500
    [Abstract] [Full Text] [Related]

  • 17. Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Tan H, Zhao J, Wang S, Zhang L, Wang H, Huang B, Liang Y, Yu X, Yang N.
    Int Immunopharmacol; 2012 Dec 01; 14(4):401-9. PubMed ID: 22922317
    [Abstract] [Full Text] [Related]

  • 18. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice.
    Wada Y, Gonzalez-Sanchez HM, Weinmann-Menke J, Iwata Y, Ajay AK, Meineck M, Kelley VR.
    J Am Soc Nephrol; 2019 Feb 01; 30(2):244-259. PubMed ID: 30622154
    [Abstract] [Full Text] [Related]

  • 19. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
    Wüthrich RP, Fan X, Ritthaler T, Sibalic V, Yu DJ, Loffing J, Kaissling B.
    Autoimmunity; 1998 Feb 01; 28(3):139-50. PubMed ID: 9867126
    [Abstract] [Full Text] [Related]

  • 20. Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
    Nowling TK, Rodgers J, Thiyagarajan T, Wolf B, Bruner E, Sundararaj K, Molano I, Gilkeson G.
    PLoS One; 2020 Feb 01; 15(3):e0230499. PubMed ID: 32187230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.